Release
📈 Stocks
Abiologics Appoints Chief AI Officer to Accelerate Synthetic Drug Discovery
(17 minutes ago)
Abiologics bolsters its R&D capabilities by hiring an AI protein design expert to advance its proprietary platform for creating synthetic D-protein therapeutics…